Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis.
Ontology highlight
ABSTRACT: The PI3K/AKT/mTOR pathway is an intracellular signalling pathway that regulates cell activation. proliferation, metabolism and apoptosis. Increasing body of data suggests that alterations in the PI3K/AKT/mTOR pathway may result in an enhanced susceptibility to autoimmunity. Multiple Sclerosis (MS) is one of the most common chronic inflammatory diseases of the central nervous system leading to demyelination and neurodegeneration. In the current study, we have firstly evaluated in silico the involvement of the mTOR network on the generation and progression of MS and on oligodendrocyte function, making use of currently available whole-genome transcriptomic data. Then, the data generated in silico were subjected to an ex-vivo evaluation. To this aim, the involvement of mTOR was validated on a
SUBMITTER: Mammana S
PROVIDER: S-EPMC5823598 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA